Skip to main content
. 2009 Mar 24;2009:794901. doi: 10.1155/2009/794901

Table 2.

Combination of HDAC and NF-κB inhibitors against synovial sarcoma cells.

Timepoint (hrs) IC50 average
MS-275 BAY 11-7085 Combination (μM)
(μM) (μM) MS-275 BAY 11
24 4.5 3.5 0.45 1.4
48 0.56 3.4 0.27 0.8